©2024 Stanford Medicine
Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer
Not Recruiting
Trial ID: NCT01688414
Purpose
This pilot clinical trial studies imaging during surgery in diagnosing patients with prostate, bladder, or kidney cancer. New diagnostic imaging procedures, may find prostate, bladder, or kidney cancer
Official Title
Utility of Fluorescence and Photoacoustic Imaging Intraoperatively to Assist With Robotic Assisted Minimally Invasive Surgery
Stanford Investigator(s)
Benjamin I. Chung
Associate Professor of Urology
James D. Brooks
Keith and Jan Hurlbut Professor
Harcharan Gill
Kathryn Simmons Stamey Professor, Emeritus
Nishita Kothary, MD
Professor of Radiology (Interventional Radiology)
Eligibility
Inclusion Criteria:
* Patients must have a pathologic confirmation of prostate cancer, bladder cancer, or kidney cancer based on previous biopsies or procedures OR a strong concern for a kidney malignancy based on computed tomography (CT) or magnetic resonance imaging (MRI) imaging
* Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
* Patients with a surgical history or anatomic variant that would preclude robot assisted laparoscopic approaches to their surgery (i.e. history of ventral hernia repair with mesh)
* Patients with medical co-morbidities who cannot tolerate laparoscopic surgery secondary to intra-abdominal carbon dioxide insufflation
* Patients with documented allergy or adverse drug reaction to indocyanine green or baseline serum creatinine greater than 1.5 mg/dL
Intervention(s):
procedure: photoacoustic imaging
procedure: fluorescence imaging
procedure: robot-assisted laparoscopic surgery
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Mark Gonzalgo
650-725-5544